|
Stock Analysis PRO New!
|
|
| Risk Assessment |
|
| Trading Strategy |
|
Teva Pharmaceutical Industries Limited stock downgraded to Hold/Accumulate
(Updated on Nov 17, 2025)
The Teva Pharmaceutical Industries Limited stock price fell by -3.23% on the last day (Monday, 17th Nov 2025) from $25.41 to $24.59. It has now fallen 3 days in a row. During the last trading day the stock fluctuated 4.12% from a day low at $24.49 to a day high of $25.50. The price has fallen in 6 of the last 10 days but is still up by 19.83% over the past 2 weeks. Volume has increased on the last day by 2 million shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 12 million shares were bought and sold for approximately $294.44 million.
The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 26.37% during the next 3 months and, with a 90% probability hold a price between $25.67 and $32.96 at the end of this 3-month period.
TEVA Signals & Forecast
The Teva Pharmaceutical Industries Limited stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $24.96. On a fall, the stock will find some support from the long-term average at approximately $21.13. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Wednesday, November 12, 2025, and so far it has fallen -4.80%. Further fall is indicated until a new bottom pivot has been found. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.
Support, Risk & Stop-loss for Teva Pharmaceutical Industries Limited stock
Teva Pharmaceutical Industries Limited finds support from accumulated volume at $24.46 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $1.01 between high and low, or 4.12%. For the last week, the stock has had daily average volatility of 3.57%.
Our recommended stop-loss: $23.58 (-4.09%) (This stock has very high daily movements and this gives very high risk. The RSI14 is 77 and this increases the risk substantially. There is a sell signal from a pivot top found 3 days ago.)
Trading Expectations (TEVA) For The Upcoming Trading Day Of Tuesday 18th
For the upcoming trading day on Tuesday, 18th we expect Teva Pharmaceutical Industries Limited to open at $24.86, and during the day (based on 14 day Average True Range), to move between $24.16 and $25.02, which gives a possible trading interval of +/-$0.85 (+/-3.53%) up or down from last closing price. If Teva Pharmaceutical Industries Limited takes out the full calculated possible swing range there will be an estimated 3.53% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $24.60 (0.04%) than the support at $24.46 (0.53%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Is Teva Pharmaceutical Industries Limited stock A Buy?
Teva Pharmaceutical Industries Limited holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold candidate.
Current score:
0.996
Hold/Accumulate
Downgraded
Predicted Fair Opening Price
Predicted fair opening price on November 18, 2025 - $24.86 ( 1.08%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
TEVA Performance
Trading levels for TEVA
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 25.87 | 5.19% |
| R2 | 25.48 | 3.62% |
| R1 | 25.24 | 2.65% |
| Price | 24.59 | |
| S1 | 24.47 | -0.485% |
| S2 | 24.23 | -1.45% |
| S3 | 23.85 | -3.02% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 25.54 | 3.86% |
| R2 | 25.13 | 2.20% |
| R1 | 24.60 | 0.0407% |
| Price | 24.59 | |
| S1 | 24.46 | -0.529% |
| S2 | 20.20 | -17.85% |
| S3 | 18.80 | -23.55% |
TEVA Dividend Payout History
| # | Ex-Date | Pay Date | Amount | Yield | |
|---|---|---|---|---|---|
| 1 | Nov 02, 2017 | Nov 27, 2017 | Dec 12, 2017 | $0.0850 | 0.515% |
| 2 | Aug 07, 2017 | Aug 25, 2017 | Sep 14, 2017 | $0.0850 | 0.463% |
| 3 | May 11, 2017 | Jun 01, 2017 | Jun 22, 2017 | $0.340 | 1.05% |
| 4 | Feb 13, 2017 | Feb 28, 2017 | Mar 20, 2017 | $0.340 | 1.01% |
| 5 | Nov 15, 2016 | Dec 01, 2016 | Dec 20, 2016 | $0.340 | 0.94% |
FAQ
Click here for our free guide on how to buy Teva Pharmaceutical Industries Limited Stock.
Buy TEVA